Najat Khan

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Najat Khan:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. CEO and President, Director Class A Common Stock 2,304,663 $9,172,558 $3.98 06 Feb 2026 Direct
RECURSION PHARMACEUTICALS, INC. CEO and President, Director Stock Option (Right to Buy) 993,944 22 Dec 2025 Direct

Insider Reports Filed by Najat Khan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 06 Feb 2026 3 -$41,249 4 CEO and President, Director 10 Feb 2026, 18:18
RXRX RECURSION PHARMACEUTICALS, INC. 22 Dec 2025 1 -$548,592 4 Chief R&D Commercial Officer, Director 29 Dec 2025, 17:24
RXRX RECURSION PHARMACEUTICALS, INC. 17 Nov 2025 1 -$72,798 4 Chief R&D Commercial Officer, Director 19 Nov 2025, 19:37
RXRX RECURSION PHARMACEUTICALS, INC. 05 Nov 2025 2 $0 4 Chief R&D Commercial Officer, Director 06 Nov 2025, 16:23
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2025 2 -$223,543 4 Chief R&D Commercial Officer, Director 19 Aug 2025, 18:22
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2025 1 -$16,133 4 Chief R&D Commercial Officer, Director 19 May 2025, 16:44
RXRX RECURSION PHARMACEUTICALS, INC. 03 Feb 2025 4 -$19,959 4 Chief R&D Commercial Officer, Director 05 Feb 2025, 16:50
RXRX RECURSION PHARMACEUTICALS, INC. 01 Aug 2024 2 $0 4 Chief R&D Commercial Officer, Director 05 Aug 2024, 17:12
RXRX RECURSION PHARMACEUTICALS, INC. 16 Apr 2024 0 $0 3 Director 25 Apr 2024, 17:08